Tag: biomedical
-

Broad Inst, Biotech Partner on Immune-Safe Crispr
A company designing synthetic proteins and the Broad Institute are developing ways to reduce the threat of edited genes producing an immune-system response.
-

Nature, Merck Establish Science Entrepreneur Prize
The scientific publisher Springer Nature and drug maker Merck are creating an annual award for early-stage companies spun-off from academic research.
-

Trial to Test Engineered Amino Acid for Schizophrenia
A clinical trial plans to test a modified amino acid as an added treatment for schizophrenia that its developers say works differently than most current drugs.
-

Engineered Virus Aids Gene Therapy Delivery
A university bio-engineering lab and start-up company are developing synthetic variations of viruses to more reliably deliver gene therapies.
-

Biotech Licenses Gene-Limiting Technology for Allergies
A biotechnology company developing treatments for skin conditions is acquiring a technology for limiting effects of genes causing asthma and allergic reactions.
-

NIH Grant Funds A.I.-Based Tuberculosis Detector
A company developing a system to quickly detect tuberculosis by analyzing sputum images received a federal grant to advance and validate its technology.
-

Wearable Sensor Analyzes Sweat, Measures Chemicals
A thin-film wearable sensor is shown in tests with volunteers to measure the presence of acids indicating gout in the chemistry of a person’s sweat.
-

Company, Univ. Lab Partner on Skin Disease Treatment
A company making regenerative skin therapies and a medical school research center are developing a spray-on treatment for a genetic skin disorder.
-

Radiology A.I. Company Raises $4M in Seed Funds
A start-up company developing systems with artificial intelligence to aid the work of radiologists is raising $4 million in its seed funding round.
-

Cell, Gene Therapy R&D/Mfring Center in Works
A consortium of companies, universities, and hospitals are creating an innovation and manufacturing center in the Boston area for cell and gene therapies.